Cardinal Health (NYSE: CAH) has been one of the best-performing stocks in one of the market’s best-performing sectors in 2026. Heading into the company’s fourth quarter earnings report for its 2026 fiscal year (FY), CAH was up more than 40% in the last 12 months. Despite mixed results, including a 2.2% revenue miss, the stock may soon reach a new 52-week high.
The only particular negative in the report came from the company’s Global Medical Products and Distribution (GMPD) unit. Revenue was down 2% year over year (YOY), and about 31 cents of its earnings were due to a one-time net benefit from IEEPA tariff refunds.
